|
|
||||||||
INFLAMMATION AND CYTOKINES
Department of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee
Submitted 30 January 2007 ; accepted in final form 15 June 2007
Norepinephrine (NE) microdialyzed in the preoptic area (POA) raises core temperature (Tc) via 1)
1-adrenoceptors (AR), quickly and independently of POA PGE2, and 2)
2-AR, after a delay and PGE2 dependently. Since systemic lipopolysaccharide (LPS) activates the central noradrenergic system, we investigated whether preoptic NE mediates LPS fever. We injected LPS (2 µg/kg iv) in guinea pigs prepared with intra-POA microdialysis probes and determined POA cerebrospinal (CSF) NE levels. We similarly microdialyzed prazosin (
1 blocker, 1 µg/µl), yohimbine (
2 blocker, 1 µg/µl), SC-560 [cyclooxygenase (COX)-1 blocker, 5 µg/µl], acetaminophen (presumptive COX-1v blocker, 5 µg/µl), or MK-0663 (COX-2 blocker, 0.5 µg/µl) in other animals before intravenous LPS and measured CSF PGE2. All of the agents were perfused at 2 µg/min for 6 h. Tc was monitored constantly. POA NE peaked within 30 min after LPS and then returned to baseline over the next 90 min. Tc increased within 12 min to a first peak at
60 min and to a second at
150 min and then declined over the following 2.5 h. POA PGE2 followed a concurrent course. Prazosin pretreatment eliminated the first Tc rise but not the second; PGE2 rose normally. Yohimbine pretreatment did not affect the first Tc rise, which continued unchanged for 6 h; the second rise, however, was absent, and PGE2 levels did not increase. SC-560 and acetaminophen did not alter the LPS-induced PGE2 and Tc rises; MK-0663 prevented both the late PGE2 and Tc rises. These results confirm that POA NE is pivotal in the development of LPS fever.
prostaglandin E2; cyclooxygenase inhibitors; noradrenergic receptor antagonists; pyrogen signaling; body temperature
This article has been cited by other articles:
![]() |
J. A. Rathner, C. J. Madden, and S. F. Morrison Central pathway for spontaneous and prostaglandin E2-evoked cutaneous vasoconstriction Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R343 - R354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |